These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 28057495)

  • 1. Iron and restless legs syndrome: treatment, genetics and pathophysiology.
    Connor JR; Patton SM; Oexle K; Allen RP
    Sleep Med; 2017 Mar; 31():61-70. PubMed ID: 28057495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered brain iron homeostasis and dopaminergic function in Restless Legs Syndrome (Willis-Ekbom Disease).
    Earley CJ; Connor J; Garcia-Borreguero D; Jenner P; Winkelman J; Zee PC; Allen R
    Sleep Med; 2014 Nov; 15(11):1288-301. PubMed ID: 25201131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iron, dopamine, genetics, and hormones in the pathophysiology of restless legs syndrome.
    Khan FH; Ahlberg CD; Chow CA; Shah DR; Koo BB
    J Neurol; 2017 Aug; 264(8):1634-1641. PubMed ID: 28236139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of iron in restless legs syndrome.
    Allen RP; Earley CJ
    Mov Disord; 2007; 22 Suppl 18():S440-8. PubMed ID: 17566122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insight into the pathophysiology of restless legs syndrome.
    Earley CJ; Allen RP; Beard JL; Connor JR
    J Neurosci Res; 2000 Dec; 62(5):623-8. PubMed ID: 11104500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pathophysiology of restless legs syndrome].
    Miyamoto M; Miyamoto T; Iwanami M; Suzuki K; Hirata K
    Brain Nerve; 2009 May; 61(5):523-32. PubMed ID: 19514512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is ferroportin-hepcidin signaling altered in restless legs syndrome?
    Clardy SL; Wang X; Boyer PJ; Earley CJ; Allen RP; Connor JR
    J Neurol Sci; 2006 Sep; 247(2):173-9. PubMed ID: 16759669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Restless legs syndrome: update on pathogenesis.
    Dauvilliers Y; Winkelmann J
    Curr Opin Pulm Med; 2013 Nov; 19(6):594-600. PubMed ID: 24048084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MRI-determined regional brain iron concentrations in early- and late-onset restless legs syndrome.
    Earley CJ; B Barker P; Horská A; Allen RP
    Sleep Med; 2006 Aug; 7(5):458-61. PubMed ID: 16740411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lower molecular weight intravenous iron dextran for restless legs syndrome.
    Cho YW; Allen RP; Earley CJ
    Sleep Med; 2013 Mar; 14(3):274-7. PubMed ID: 23333678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restless legs syndrome-associated MEIS1 risk variant influences iron homeostasis.
    Catoire H; Dion PA; Xiong L; Amari M; Gaudet R; Girard SL; Noreau A; Gaspar C; Turecki G; Montplaisir JY; Parker JA; Rouleau GA
    Ann Neurol; 2011 Jul; 70(1):170-5. PubMed ID: 21710629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased transferrin receptor expression by neuromelanin cells in restless legs syndrome.
    Connor JR; Wang XS; Patton SM; Menzies SL; Troncoso JC; Earley CJ; Allen RP
    Neurology; 2004 May; 62(9):1563-7. PubMed ID: 15136682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain iron accumulation in a blood donor family with restless legs syndrome.
    Lillo-Triguero L; Del Castillo A; Guzman de Villoria J; Moran-Jimenez MJ; Guillem A; Peraita-Adrados R
    Rev Neurol; 2019 Feb; 68(3):107-110. PubMed ID: 30687917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Caenorhabditis elegans and its applicability to studies on restless legs syndrome.
    Chen P; Ijomone OM; Lee KH; Aschner M
    Adv Pharmacol; 2019; 84():147-174. PubMed ID: 31229169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous iron dextran for severe refractory restless legs syndrome.
    Ondo WG
    Sleep Med; 2010 May; 11(5):494-6. PubMed ID: 20371212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iron-deficiency and dopaminergic treatment effects on RLS-Like behaviors of an animal model with the brain iron deficiency pattern of the restless legs syndrome.
    Allen RP; Earley CJ; Jones BC; Unger EL
    Sleep Med; 2020 Jul; 71():141-148. PubMed ID: 32094092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New Insights into the Neurobiology of Restless Legs Syndrome.
    Ferré S; García-Borreguero D; Allen RP; Earley CJ
    Neuroscientist; 2019 Apr; 25(2):113-125. PubMed ID: 30047288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mineral absorption is an enriched pathway in a brain region of restless legs syndrome patients with reduced MEIS1 expression.
    Sarayloo F; Dionne-Laporte A; Catoire H; Rochefort D; Houle G; Ross JP; Akçimen F; Barros Oliveira R; Turecki G; Dion PA; Rouleau GA
    PLoS One; 2019; 14(11):e0225186. PubMed ID: 31725784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restless Leg Syndrome/Willis-Ekbom Disease Pathophysiology.
    Allen RP
    Sleep Med Clin; 2015 Sep; 10(3):207-14, xi. PubMed ID: 26329430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Profile of altered brain iron acquisition in restless legs syndrome.
    Connor JR; Ponnuru P; Wang XS; Patton SM; Allen RP; Earley CJ
    Brain; 2011 Apr; 134(Pt 4):959-68. PubMed ID: 21398376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.